Q4 2019 Akebia Therapeutics Inc Earnings Call

10/3/2020 9:00

Conference Call Akebia Therapeutics Inc

Akebia Therapeutics Inc Conference call or earnings call will be held on Mar 10, 2020 via an 800 number (toll-free). During the earnings conference call's session Akebia Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Akebia Therapeutics Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
Incorporated in Delaware in 2007, we are a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with serious unmet medical needs. HIF is the primary regulator of the production of red blood cells, or RBCs, in the body and a potentially novel mechanism for the treatment of anemia secondary to chronic kidney disease, or CKD. Pharmacologic modulation of the HIF pathway may also have broader therapeutic applications in acute renal failure, organ protection, ischemia-reperfusion injury, cancer, ophthalmology, and inflammatory diseases. Anemia is a serious medical condition in which blood is deficient in RBCs and hemoglobin, each of which is critical in delivering oxygen to tissue. Anemia generally exists when hemoglobin, a protein in RBCs that carries oxygen, is less than 13 g/dL in men or 12 g/dL in women.    
Read more Conference Call

Akebia Therapeutics Inc (AKBA)

245 First Street, Cambridge Massachusetts 02142, United States